AP
SWAV

AtonRa Partners’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

AtonRa Partners’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$766K Sell
4,022
-352
-8% -$66.5K 1.53% 11
2023
Q3 		$871K Sell
4,374
-128
-3% -$30.3K 1.83% 2
2023
Q2 		$1.28M Sell
4,502
-2,104
-32% -$584K 1.99% 3
2023
Q1 		$1.43M Sell
6,606
-929
-12% -$181K 2.09% 6
2022
Q4 		$1.55M Sell
7,535
-2,448
-25% -$619K 1.97% 7
2022
Q3 		$2.78M Sell
9,983
-5,213
-34% -$1.33M 2.73% 2
2022
Q2 		$2.9M Sell
15,196
-10,266
-40% -$1.81M 2.67% 1
2022
Q1 		$5.28M Sell
25,462
-7,938
-24% -$1.31M 2.87% 1
2021
Q4 		$5.96M Sell
33,400
-1,215
-4% -$240K 2.07% 5
2021
Q3 		$7.13M Buy
34,615
+3,252
+10% +$638K 2.38% 4
2021
Q2 		$5.95M Sell
31,363
-807
-3% -$132K 2.18% 4
2021
Q1 		$4.19M Buy
32,170
+7,593
+31% +$911K 1.87% 5
2020
Q4 		$2.55M Buy
+24,577
New +$2.13M 1.25% 31

Other funds holding SWAV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AtonRa Partners's SWAV Position: Q4 2023 in Review

AtonRa Partners reduced its Shockwave Medical, Inc. Common Stock (SWAV) stake by 8% in Q4 2023, selling an estimated $66.5K and leaving 4,022 shares worth $766K. The position accounts for 1.53% of the portfolio, ranked #11.

AtonRa Partners first reported a position in SWAV in Q4 2020 and has held it in 13 quarters since. The position peaked at $7.13M in Q3 2021. 427 funds tracked by Wall St. Rank hold SWAV as of Q4 2023.

  • AtonRa Partners held 4,022 shares of Shockwave Medical, Inc. Common Stock worth $766K as of Q4 2023.
  • AtonRa Partners sold 352 Shockwave Medical, Inc. Common Stock shares in Q4 2023, an estimated $66.5K.
  • Shockwave Medical, Inc. Common Stock made up 1.53% of AtonRa Partners's portfolio in Q4 2023, its #11 holding.
  • AtonRa Partners first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2020 and has held it in 13 quarters since.
  • AtonRa Partners's Shockwave Medical, Inc. Common Stock position peaked at $7.13M in Q3 2021.
  • 427 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2023.

Based on AtonRa Partners's 13F filing for Q4 2023, filed 5 Feb 2024.